<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01057082</url>
  </required_header>
  <id_info>
    <org_study_id>F100107001</org_study_id>
    <secondary_id>F31AT005384-01</secondary_id>
    <nct_id>NCT01057082</nct_id>
  </id_info>
  <brief_title>Dietary Supplements and Aging Muscle</brief_title>
  <official_title>Dietary Supplements and Aging Muscle: Specific Amino Acids to Combat Sarcopenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether older adults (ages 65-89) who consume the
      dietary supplement Juven (Abbott Laboratories) versus placebo for 6 months will demonstrate
      increases in fat-free mass, muscle volume,and physical function.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fat-free mass as determined by a four-compartment model of body composition</measure>
    <time_frame>Baseline, 3-months, 6-months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Appendicular lean mass as determined by dual energy X-ray absorptiometry</measure>
    <time_frame>Baseline, 3-months, 6-months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle volume as determined by magnetic resonance imaging</measure>
    <time_frame>Baseline and 6-months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function as determined by questionnaire and a battery of physical performance tests</measure>
    <time_frame>Baseline and 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Juven</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the treatment arm will receive the dietary supplement Juven.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Juven</intervention_name>
    <description>Participants in the treatment arm will be asked to consume 2 packets of Juven drink mix each day for a period of six months.</description>
    <arm_group_label>Juven</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Juven</intervention_name>
    <description>Participants in the placebo arm will be asked to consume two packets of an orange-flavored drink mix each day for a period of six months.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 65-89

          -  Ambulatory

        Exclusion Criteria:

          -  Cognitive impairment

          -  History of renal or hepatic disease

          -  History of hypotension

          -  History of peripheral artery disease

          -  Uncontrolled hypertension

          -  Uncontrolled diabetes

          -  Self-reported claustrophobia

          -  Current smoker

          -  Steroid or androgen use with the previous 3 months

          -  Individuals with pacemakers and defibrillators
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amy C Ellis, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2010</study_first_submitted>
  <study_first_submitted_qc>January 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2010</study_first_posted>
  <last_update_submitted>March 16, 2012</last_update_submitted>
  <last_update_submitted_qc>March 16, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Amy Ellis</investigator_full_name>
    <investigator_title>Registered Dietitian; Graduate Fellow</investigator_title>
  </responsible_party>
  <keyword>Sarcopenia</keyword>
  <keyword>Aging</keyword>
  <keyword>Muscle</keyword>
  <keyword>Dietary Supplement</keyword>
  <keyword>HMB</keyword>
  <keyword>Arginine</keyword>
  <keyword>Glutamine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

